Evidence map›Paper›PMID 40064995›Full record

ArticleScientific reports2025

Unraveling the molecular basis of membrane-associated release of coxsackievirus B3.

Rodrigo Arce, Martín Soñora, Iván Andreu-Moreno, Pilar Moreno, Gonzalo Moratorio, Rafael Sanjuán

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rodrigo ArceVirus Evolution Laboratory, Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, Paterna, Spain. rodrigo.arce@uv.es.
Martín SoñoraBiomolecular Simulations Group, Institut Pasteur de Montevideo, Mataojo 2020, Montevideo, 11400, Uruguay.
Iván Andreu-MorenoVirus Evolution Laboratory, Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, Paterna, Spain.
Pilar MorenoMolecular Virology Laboratory, Center for Nuclear Research, Faculty of Sciences, Universidad de la República, Montevideo, Uruguay.
Gonzalo MoratorioMolecular Virology Laboratory, Center for Nuclear Research, Faculty of Sciences, Universidad de la República, Montevideo, Uruguay.
Rafael SanjuánVirus Evolution Laboratory, Institute for Integrative Systems Biology (I2SysBio), Universitat de València-CSIC, Paterna, Spain. rafael.sanjuan@uv.es.

Funding

Agencia Nacional de Investigación e Innovación MOV_CA_2021_1_171985Comisión Sectorial de Investigación Científica Programa MIAERC Advanced Grant 101019724-EVADERFOCEM - Fondo para la Convergencia Estructural del Mercosur COF 03/11Ministerio de Ciencia e Innovación PID2020-118602RB-I00
6 · The paper itself

Abstract

Coxsackievirus B3 (CVB3), a member of the Enterovirus genus within the Picornaviridae family, has emerged as a key model for studying viral evolution and pathogenesis. Although traditionally considered obligate lytic viruses, recent research reveals that enteroviruses can also be released non-lytically within extracellular vesicles (EVs). This study explores the impact of mutations at position 63 of the VP3 capsid protein on CVB3 fitness and release mechanisms by substituting asparagine at this position with aromatic, charged, and aliphatic amino acids. We show that mutations at position 63 significantly affect viral release mechanisms and viral spread in cell culture. Specifically, aromatic mutations (N63H, N63Y, N63F, N63W) and the N63D mutation reduce the release of membrane-associated viral particles, while aromatic residues increase viral spread in cell culture and plaque size under specific conditions. These findings suggest that N63 mutations alter protomer interactions, influencing viral release, spread, and plaque formation, providing insights into the molecular mechanisms of CVB3 egress.

Indexed as

Capsid ProteinsCell MembraneEnterovirus B, HumanVirus ReleaseAnimalsCell LineCoxsackievirus InfectionsExtracellular VesiclesHumansMutationCapsid ProteinsCoxsackievirus B3EnterovirusesPlaque sizeViral releaseViral spread

Identifiers

PMID40064995
PMCPMC11893736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.